Interpretation of 5-Year Rate Changes Data
5-Year Rate Changes - Mortality
Tennessee, 2018-2022
Ages 50+, Both Sexes, All Races (incl Hisp)
Bar graph with 20 items Since the overall trend is negative (-1.80 with a 95% confidence interval from -2.40 to -1.40 ), the overall cancer rate is falling.
Stable when 95% confidence interval of annual percent change includes 0.
The rate for the following cancers was statistically stable in the time period:
- Esophagus with a trend of -3.1 and a 95% confidence interval from -6.4 to 0.3.
- Cervix (Female) with a trend of -0.7 and a 95% confidence interval from -1.9 to 3.9.
- Breast (Female) with a trend of -0.4 and a 95% confidence interval from -1.0 to 1.5.
- Prostate (Male) with a trend of -0.2 and a 95% confidence interval from -1.3 to 1.4.
- Thyroid with a trend of 0.2 and a 95% confidence interval from -0.9 to 1.5.
- Liver & Bile Duct with a trend of 0.3 and a 95% confidence interval from -1.1 to 1.2.
- Oral Cavity & Pharynx with a trend of 3.0 and a 95% confidence interval from -0.3 to 6.7.
Rising when 95% confidence interval of annual percent change is above 0.
The rate for the following cancers rose in the time period:
- Pancreas with a trend of 0.2# and a 95% confidence interval from 0.1 to 0.3.
- Bladder with a trend of 0.3# and a 95% confidence interval from 0.1 to 0.6.
- Uterus (Corp/Uterus NOS) (Fem) with a trend of 2.0# and a 95% confidence interval from 0.9 to 5.7.
Falling when 95% confidence interval of annual percent change is below 0.
The rate for the following cancers fell in the time period:
- Ovary (Female) with a trend of -5.3# and a 95% confidence interval from -8.5 to -2.6.
- Lung & Bronchus with a trend of -3.9# and a 95% confidence interval from -4.7 to -3.4.
- Melanoma of the Skin with a trend of -3.2# and a 95% confidence interval from -5.9 to -1.8.
- Stomach with a trend of -2.6# and a 95% confidence interval from -3.0 to -2.3.
- Leukemia with a trend of -2.2# and a 95% confidence interval from -6.1 to -0.9.
- Non-Hodgkin Lymphoma with a trend of -2.2# and a 95% confidence interval from -2.5 to -2.0.
- Colon & Rectum with a trend of -2.1# and a 95% confidence interval from -4.0 to -1.9.
- Brain & ONS with a trend of -0.7# and a 95% confidence interval from -1.0 to -0.4.
- Kidney & Renal Pelvis with a trend of -0.3# and a 95% confidence interval from -0.5 to -0.1.
Notes:
Created by statecancerprofiles.cancer.gov on 11/10/2024 2:24 pm.
Source: Death data provided by the National Vital Statistics System public use data file. Death rates calculated by the National Cancer Institute using SEER*Stat . Death rates (deaths per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used with mortality data.
AAPCs are calculated by the Joinpoint Regression Program and are based on APCs. Data are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84,85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ or unless otherwise specified. Population counts for denominators are based on Census populations as modifed by NCI. The US Population Data File is used with SEER November 2021 data. Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html. Please note that the data comes from different sources. Due to data availability issues, the time period used in the calculation of the joinpoint regression model may differ for selected areas. Please refer to the source for each graph for additional information.